Home » Topics » Science » New compound

New compound
RSS

Bispecific-anchored cytotoxicity activator antibody induces ovarian cancer cell death

Oct. 1, 2018

DS-21412020 demonstrates potent activity against respiratory pathogens

Sep. 26, 2018

Thiomannosides, new oral FimH inhibitors for the treatment of urinary tract infections

Sep. 25, 2018

UCB-9608 is a potent and orally available immunosuppressive agent with promising in vivo activity

Sep. 19, 2018

Sanofi achieves KEAP1/Nrf2 inhibition with bioavailable small molecules

Sep. 19, 2018

CL-656 demonstrates promise in melanoma and colon cancer models

Sep. 18, 2018

Targeting alpha-4 integrin alleviates allergic conjunctivitis in animal models

Sep. 17, 2018

Strategic alliance between Bayer and Evotec results in the discovery of BAY-2395840

Sep. 17, 2018

DGMIF presents DN-200434 for ATC radioiodine therapy improvement

Sep. 17, 2018

AbbVie presents novel optimized GABA-B PAMs with efficacy in animal models of seizure

Sep. 17, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...